# Vaccine Therapy in Treating Patients With Metastatic Melanoma

> **NCT00022568** · PHASE1 · UNKNOWN · sponsor: **Herbert Irving Comprehensive Cancer Center**

## Conditions studied

- Melanoma (Skin)

## Interventions

- **BIOLOGICAL:** recombinant vaccinia-TRICOM vaccine

## Key facts

- **NCT ID:** NCT00022568
- **Lead sponsor:** Herbert Irving Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2001-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00022568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00022568, "Vaccine Therapy in Treating Patients With Metastatic Melanoma". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00022568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*